A criminal case has been initiated against a number of officials.
On February 10, the Anti-Corruption Agency of Uzbekistan reported that the Law Enforcement Agents have initiated a case against the Agency for the development of the pharmaceutical industry of Uzbekistan for embezzlement, and a large number of financial shortcomings (hereinafter the Agency).
In addition, the former director of the State Unitary Enterprise "The state centre for expertise and standardization of medicines, medical devices and equipment " under the Agency for the Development of the Pharmaceutical Industry, Sardor Koriev, several of his accomplices and a number of officials had been taken into custody as part of the investigation of the criminal case on the death of children who took Doc-1 Max and Ambronol syrups.
An investigation is underway to determine the circle of persons guilty of importing and allowing low-quality drugs to be used in Uzbekistan.
On December 30, 2022, during the meeting, Shavkat Mirziyoyev touched upon the healthcare sector and sharply criticized the deaths of children after taking the drug "Doc-1 Max".
The death of children in Samarkand and Kashkadarya showed the state of affairs on the ground, and lack of control. Today I fired the head of the agency, Sardor Kariev. All officials who allowed this will answer before the law,” the president said.
19 children died in Samarkand after taking an Indian imported cold syrup. A toxic substance was found in the medication, which was 300 times higher than the norm, and laboratory tests were not carried out properly. They received certificates of conformity. However, in the process of research, the requirements of regulatory documents were blatantly violated, as a result of which low-quality drugs were prescribed. The Government of India reacted to the situation and opened a criminal case against the company Marion Biotech.
The "Regulations on the procedure for licensing pharmaceutical activities", approved by the Resolution of the Cabinet of Ministers of the Republic of Uzbekistan No. 91 dated May 13, 2010, is controlled by the state over the implementation of pharmaceutical activities. The main task of licensing is to ensure the quality, efficiency and safety of drug care, and to prevent unprepared and unscrupulous business entities from entering the pharmaceutical market.
The question: How did it happen that the State Unitary Enterprise under the Agency for Development of Pharmaceutical Industry of Uzbekistan permitted the sale of Indian drugs despite violations of the requirements?
Comments (0)